Menéndez-Arias Luis
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Cantoblanco, Spain.
Prog Nucleic Acid Res Mol Biol. 2002;71:91-147. doi: 10.1016/s0079-6603(02)71042-8.
Reverse transcription involves the conversion of viral genomic RNAinto proviral double-stranded DNA that integrates into the host cell genome. Cellular DNA polymerases replicate the integrated viral DNA and RNA polymerase II transcribes the proviral DNA into RNA genomes that are packaged into virions. Although mutations can be introduced at any of these replication steps, reverse transcriptase (RT) errors play a major role in retroviral mutation. This review summarizes our current knowledge on fidelity of reverse transcriptases. Estimates of retroviral mutation rates or fidelity of retroviral RTs are discussed in the context of the different techniques used for this purpose (i.e., retroviral vectors replicated in culture, misinsertion and mispair extension fidelity assay, etc.). In vitro fidelity assays provide information on the RT's accuracy during the elongation reaction of DNA synthesis. In addition, other steps such as initiation of reverse transcription, or strand transfer, and factors including viral proteins such as Vpr [in the case of the human immunodeficiency virus type 1 (HIV-1)] have been shown to influence fidelity. A comprehensive description of the effect of amino acid substitutions on the fidelity of HIV-1 RT is presented. Published data point to certain dNTP-binding residues, as well as to various amino acids involved in interactions with the template or the primer strand, and to residues in the minor groove-binding track as major components of the fidelity center of retroviral RTs. Implications of these studies include the design of novel therapeutic strategies leading to virus extinction, by increasing the viral mutation rate beyond a tolerable threshold.
逆转录涉及将病毒基因组RNA转化为前病毒双链DNA,该双链DNA整合到宿主细胞基因组中。细胞DNA聚合酶复制整合的病毒DNA,而RNA聚合酶II将前病毒DNA转录为RNA基因组,这些基因组被包装到病毒粒子中。尽管在这些复制步骤中的任何一步都可能引入突变,但逆转录酶(RT)错误在逆转录病毒突变中起主要作用。本综述总结了我们目前对逆转录酶保真度的认识。在用于此目的的不同技术(即,在培养物中复制的逆转录病毒载体、错插入和错配延伸保真度测定等)的背景下,讨论了逆转录病毒突变率或逆转录病毒RT保真度的估计。体外保真度测定提供了关于DNA合成延伸反应期间RT准确性的信息。此外,已证明其他步骤,如逆转录的起始或链转移,以及包括病毒蛋白如Vpr(就人类免疫缺陷病毒1型(HIV-1)而言)等因素会影响保真度。本文全面描述了氨基酸取代对HIV-1 RT保真度的影响。已发表的数据指出某些dNTP结合残基,以及与模板或引物链相互作用中涉及的各种氨基酸,以及小沟结合轨道中的残基是逆转录病毒RT保真度中心的主要组成部分。这些研究的意义包括通过将病毒突变率提高到可耐受阈值以上来设计导致病毒灭绝的新型治疗策略。